APA (7th ed.) Citation

Facon, T., Kumar, S., Plesner, T., Orlowski, R. Z., Moreau, P., Bahlis, N., . . . Usmani, S. Z. (2019). Daratumumab plus lenalidomide and dexamethasone for untreated myeloma. The New England journal of medicine, 380(22), . https://doi.org/10.1056/NEJMoa1817249

Chicago Style (17th ed.) Citation

Facon, Thierry, et al. "Daratumumab Plus Lenalidomide and Dexamethasone for Untreated Myeloma." The New England Journal of Medicine 380, no. 22 (2019). https://doi.org/10.1056/NEJMoa1817249.

MLA (9th ed.) Citation

Facon, Thierry, et al. "Daratumumab Plus Lenalidomide and Dexamethasone for Untreated Myeloma." The New England Journal of Medicine, vol. 380, no. 22, 2019, https://doi.org/10.1056/NEJMoa1817249.